WST West Pharmaceutical Services Inc

  1. Stocks
  2. Healthcare
  3. NYSE: WST

Price (delayed)

$328.82

Market cap

$23.23B

P/E Ratio

43.73

Dividend/share

$0.87

EPS

$7.52

Enterprise value

$23.03B

?
Relative Growth: Rel. Growth: 74
Relative Strength: Rel. Strength: 80
Relative Valuation: Rel. Valuation: 26
Relative Profitability: Rel. Profitability: 76

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, ...

Highlights
The gross profit has grown by 17% YoY and by 6% from the previous quarter
WST's EPS is up by 17% year-on-year and by 10% since the previous quarter
WST's equity is up by 11% year-on-year but it is down by 6% since the previous quarter
The stock's price to earnings (P/E) is 21% more than its last 4 quarters average of 36.2
West Pharmaceutical Services's quick ratio has decreased by 14% from the previous quarter
Sector: Healthcare
Industry: Medical Instruments & Supplies
Website: http://www.westpharma.com
Peers: BDX ICUI SYK BAX

Key stats

What are the main financial stats of WST

WST stock price

How has the West Pharmaceutical Services stock price performed over time
Intraday
-0.46%
1 week
4.55%
1 month
5.37%
1 year
46.2%
YTD
19.51%
QTD
31.19%

Financial performance

How have West Pharmaceutical Services's revenue and profit performed over time
Revenue
$3.22B
Gross profit
$1.17B
Operating income
$655M
Net income
$542.7M
Gross margin
36.3%
Net margin
16.8%
WST's operating income is up by 18% YoY and by 12% from the previous quarter
The gross profit has grown by 17% YoY and by 6% from the previous quarter
The net income has grown by 16% YoY and by 10% from the previous quarter
West Pharmaceutical Services's revenue has increased by 11% YoY and by 4.8% from the previous quarter

Price vs fundamentals

How does WST's price correlate with its fundamentals

Growth

What is West Pharmaceutical Services's growth rate over time

Valuation

What is West Pharmaceutical Services stock price valuation
WST P/E details
P/E
43.73
P/B
7.92
P/S
7.35
EV/EBIT
33.52
EV/EBITDA
26.66
EV/Sales
7.15
The stock's price to earnings (P/E) is 21% more than its last 4 quarters average of 36.2
WST's EPS is up by 17% year-on-year and by 10% since the previous quarter
The price to book (P/B) is 32% higher than the last 4 quarters average of 6.0 but 14% lower than the 5-year quarterly average of 9.2
WST's equity is up by 11% year-on-year but it is down by 6% since the previous quarter
The P/S is 25% above the last 4 quarters average of 5.9 but 11% below the 5-year quarterly average of 8.3
West Pharmaceutical Services's revenue has increased by 11% YoY and by 4.8% from the previous quarter

Efficiency

How efficient is West Pharmaceutical Services business performance
WST's return on invested capital is up by 10% since the previous quarter and by 8% year-on-year
WST's return on sales is up by 7% since the previous quarter and by 5% year-on-year
West Pharmaceutical Services's ROE has increased by 7% from the previous quarter and by 2.3% YoY
The company's return on assets rose by 6% QoQ

Dividends

What is WST's dividend history
Dividend details
DPS
$0.87
Dividend yield
0.26%
Payout ratio
11.6%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did West Pharmaceutical Services financials performed over time
The total liabilities has increased by 20% year-on-year and by 2.3% since the previous quarter
West Pharmaceutical Services's quick ratio has decreased by 14% from the previous quarter
WST's debt is 89% smaller than its equity
WST's equity is up by 11% year-on-year but it is down by 6% since the previous quarter
The debt to equity has grown by 10% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.